Sichuan Hebang Biotechnology Co Ltd (603077) — Cash Flow-to-Debt Ratio
Sichuan Hebang Biotechnology Co Ltd (603077) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥165.40 Million could theoretically repay 0% of its total liabilities (CN¥10.53 Billion) in one year. See Sichuan Hebang Biotechnology Co Ltd (603077) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sichuan Hebang Biotechnology Co Ltd Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Sichuan Hebang Biotechnology Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see Sichuan Hebang Biotechnology Co Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Year-by-year debt coverage analysis for Sichuan Hebang Biotechnology Co Ltd. Check Sichuan Hebang Biotechnology Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥1.08 Billion | CN¥10.25 Billion | ▲ +138.8% |
| 2024 | 0.04x | CN¥467.93 Million | CN¥10.64 Billion | ▼ -5.3% |
| 2023 | 0.05x | CN¥200.76 Million | CN¥4.32 Billion | ▼ -92.4% |
| 2022 | 0.61x | CN¥2.64 Billion | CN¥4.34 Billion | ▼ -37.4% |
| 2021 | 0.97x | CN¥3.20 Billion | CN¥3.29 Billion | ▲ +805.6% |
| 2020 | 0.11x | CN¥368.85 Million | CN¥3.43 Billion | ▲ +99.9% |
| 2019 | 0.05x | CN¥162.92 Million | CN¥3.03 Billion | ▼ -88.1% |
| 2018 | 0.45x | CN¥944.39 Million | CN¥2.09 Billion | ▲ +368.7% |
| 2017 | 0.10x | CN¥176.94 Million | CN¥1.83 Billion | ▼ -63.9% |
| 2016 | 0.27x | CN¥575.26 Million | CN¥2.15 Billion | ▲ +174.7% |
| 2015 | 0.10x | CN¥449.20 Million | CN¥4.62 Billion | ▲ +108.3% |
| 2014 | 0.05x | CN¥204.67 Million | CN¥4.38 Billion | ▲ +126.3% |
| 2013 | -0.18x | CN¥-407.48 Million | CN¥2.29 Billion | ▼ -316.2% |
| 2012 | 0.08x | CN¥134.96 Million | CN¥1.64 Billion | ▼ -65.2% |
| 2011 | 0.24x | CN¥552.56 Million | CN¥2.34 Billion | ▲ +53.0% |
| 2010 | 0.15x | CN¥330.77 Million | CN¥2.14 Billion | ▲ +443.4% |
| 2009 | 0.03x | CN¥68.97 Million | CN¥2.43 Billion | — |